Claudia Pérez-Carretero

6PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersRespiratory diseasesHaematological tumoursCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 10, 2026
ZMYM3 mutations modulate histone acetylation and cooperate with NOTCH1 mutations in chronic lymphocytic leukemia.

|Jul 01, 2024
Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis.

Claudia Pérez Carretero, Teresa González, Miguel Quijada Álamo

|Sep 09, 2023
The Five "Ws" of Frailty Assessment and Chronic Lymphocytic Leukemia: Who, What, Where, Why, and When.

Isabel González-Gascón-Y-Marín, Mónica Ballesteros-Andrés, Sara Martínez-Flores

|Apr 26, 2022
TRAF3 alterations are frequent in del-3'IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features.

Claudia Pérez-Carretero, María Hernández-Sánchez, Teresa González

|Jun 02, 2021
The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment.

Claudia Pérez-Carretero, Isabel González-Gascón-Y-Marín, Ana E Rodríguez-Vicente

|Apr 30, 2021
From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct.

Isabel González-Gascón-Y-Marín, Carolina Muñoz-Novas, Ana-Eugenia Rodríguez-Vicente

Pageof 1

Frequent Collaborators

4 joint publications

Isabel González-Gascón-Y-Marín

4 joint publications

Ana-Eugenia Rodríguez-Vicente

4 joint publications

Jesús-María Hernández-Rivas

3 joint publications

Julio Davila-Valls